ImmunoGenesis, Inc. Email Format

Biotechnology ResearchTexas, United States11-50 Employees

ImmunoGenesis, Inc. is a clinical-stage biotechnology company based in Houston, Texas, focused on immuno-oncology with an emphasis on immune-excluded or cold tumors. It develops therapeutic approaches designed to overcome mechanisms that suppress the immune response in these tumors, aiming to trigger a robust anti-tumor immune reaction. The company pursues a drug development strategy rooted in the specific pathology of cold tumors, seeking to reimagine how such cancers are treated.

Its target patients are those whose cancers exhibit immune exclusion and resistance to current immunotherapies; the work centers on the company’s lead program IMGS-001. ImmunoGenesis operates within the biotechnology research industry and engages in partnerships to accelerate development, including a strategic collaboration with BostonGene announced in April 2026 to advance IMGS-001. The organization maintains a relatively small to mid-sized team and is active in clinical development efforts from its Houston base.

Sign up for free to view info

Company overview Employee directory